SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics 2014. CA Cancer J Clin. 2014;64:929.
  • 2
    Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-46, HHS Publication No. (SMA) 13-4795. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013.
  • 3
    Korper, SP, Raskin IE. Substance Abuse by Older Adults: Estimates of Future Impact on the Treatment System. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2008.
  • 4
    Bartels SJ, Blow FC, Brockmann LM, Van Citters AD. Substance Abuse and Mental Health Among Older Americans: The State of the Knowledge and Future Directions. Prepared for: Older American Substance Abuse and Mental Health Technical Assistance Center Substance Abuse and Mental Health Services Administration. Rockville, MD: WESTAT; 2005.
  • 5
    Arndt S, Clayton R, Schultz SK. Trends in substance abuse treatment 1998-2008: increasing older adult first-time admissions for illicit drugs. Am J Geriatr Psychiatry. 2011;9:704711.
  • 6
    Chang G, Meadows ME, Jones JA, Antin JH, Orav EJ. Substance use and survival after treatment for chronic myelogenous leukemia (CML) or myelodysplastic syndrome (MDS). Am J Drug Alcohol Abuse. 2010;36:16.
  • 7
    Polednak AP. Documentation of alcohol use in hospital records of newly diagnosed cancer patients: a population-based study. Am J Drug Alcohol Abuse. 2007;33:403409.
  • 8
    Heidenreich A, Bastian PJ, Bellmunt J, et al. EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol. 2014;65:467479.
  • 9
    Smith HS, Barkin RL, Painful boney metastases. Am J. Ther. 2014;21:106130.
  • 10
    Green CR, Montague L, Hart-Johnson TA. Consistent and breakthrough pain in diverse advanced cancer patients: a longitudinal examination. J Pain Symptom Manage. 2009;37:831847.
  • 11
    Passik SD, Theobald DE. Managing addiction in advanced cancer patients: Why bother? J Pain Symptom Manage. 2000;19:229234.
  • 12
    Bailey F, Davies A. The misuse/abuse of antihistamine antiemetic medication (cyclizine) by cancer patients. Palliat Med. 2008;22:869871.
  • 13
    Starr, TD, Rogak LJ, Passik SD. Substance abuse in cancer pain. Curr Pain Headache Rep. 2010;14:268275.
  • 14
    Whitcomb LA, Kirsh KL, Passik SD. Substance abuse issues in cancer pain. Curr Pain Headache Rep. 2002;6:183190.
  • 15
    Warren JL, Klabunder CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data-content, research application and generalizability to the United States elderly population. Med Care. 2002;40(supp):IV3–IV-18.
  • 16
    Adamo MB, Johnson CH, Rhul JL, Dickie LA, eds. 2013 SEER Program Coding and Staging Manual. NIH Publication number 13-5581. Bethesda, MD: National Cancer Institute; 2014.
  • 17
    Brown ML, Riley GF, Schussler N, et al. Estimating care costs related to cancer treatment from SEER-Medicare data. Med Care. 2002;40(suppl):IV104–IV-117.
  • 18
    Warren JL, Yabroff KR, Meekins A, et al. Evaluation of trends in the cost of initial cancer treatment Journal of the National Cancer Institute. 2008;100:888897.
  • 19
    Yabroff KR, Lamont EB, Mariotto A, et al. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst. 2008;100:630641.
  • 20
    Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care. 1998;36:827.
  • 21
    Greene WH. Econometric Analysis. 4th edition. Upper Saddle River, NJ: Prentice Hall; 2000.
  • 22
    Klabunde CN, Warren JL, Legler JMl. Assessing comorbidity using claims data-an overview. Med Care. 2002;40(suppl):IV26–IV-35.
  • 23
    Spreeuwenberg MD, Bartak A, Croon MA, et al. The multiple propensity score a control for bias in the comparison of more than two treatment arms—an introduction from a case study in mental health. Med Care. 2010;48:166174.
  • 24
    Jayadevappa, R, Malkowicz SB, Chhatre S, Johnson JC, Gallo JJ. The burden of depression in prostate cancer. Psychooncology. 2012;21:13381345.
  • 25
    Ballantyne JC. Chronic pain following treatment for cancer: the role of opioids. Oncologist. 2003;8:567575.
  • 26
    Johanes C, Monoarfa RA, Ismail RI, Umbas R. Anxiety level of early- and late-stage prostate cancer patients. Prostate Int. 2013;1:177182.
  • 27
    Passik SD, Roth AJ. Anxiety symptoms and panic attacks preceding pancreatic cancer diagnosis. Psychooncology. 1999;8 268272.
  • 28
    Virning BA, McBean M. Administrative data for public health surveillance and planning. Annu Rev Public Health. 2001;22:213230.